BioSpace News Archive

BioMidwest

Philips Introduces Technology Maximizer to Boost Imaging Equipment Performance and Clinical Capabilities, and Help Manage Security Risk

Technology Maximizer provides confidence to radiology and cardiology department leaders and clinicians that their systems are up to date and compliant at a fraction of the cost of individual upgrades.

November 28, 2017

·

3 min read

Astellas to Present New Data Exploring Gilteritinib in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients at the 2017 ASH

The wide selection of abstracts showcases the company’s full-scale development program across the FLT3 mutation-positive AML care continuum-from newly-diagnosed to relapsed or refractory patients.

November 28, 2017

·

6 min read

Policy

Agendia’s MammaPrint Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Unique Category 1 CPT Code

Agendia announces that its MammaPrint 70-Gene Breast Cancer Risk-of-Recurrence Test has received a favorable payment determination for CY 2018 from the CMS for its new CPT code.

November 28, 2017

·

2 min read

Genetown

Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

The stock option vests 25% on the first anniversary of the grant date, with the remaining 75% to vest in monthly installments over the three years thereafter, and has a ten-year term.

November 28, 2017

·

1 min read

Biotech Bay

Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent

This advanced cell separation technology, known as Buoyancy-Activated Cell Separation, or BACS, is key to the ongoing development of Cesca’s CAR-TXpress™ platform.

November 28, 2017

·

4 min read

Pharm Country

Merck Announces Increased Quarterly Dividend and $10B Share Repurchase Authorization

The Board also authorized an additional $10 billion of treasury stock purchases with no time limit for completion.

November 28, 2017

·

3 min read

Drug Development

Aptevo Therapeutics Announces Plans to Conduct Phase II Study of Otlertuzumab in Peripheral T-Cell Lymphoma

In addition, the company expects to file 2 Investigational New Drug (IND) applications in 2018 for 2 bispecific antibody candidates

November 28, 2017

·

8 min read

Drug Development

Cytovance Biologics Announces Bexion Pharmaceuticals Has Chosen Cytovance to Manufacture the Protein Component and Active Ingredient Of Bexion’s First Clinical Compound, BXQ-350

An ongoing supply of this protein will support Bexion’s continued drug development efforts, including planned Phase II clinical trials.

November 28, 2017

·

2 min read

BioMidwest

MedyMatch Continues to Deploy Intelligence-Based Clinical Decision Support Technology Across the Healthcare Industry

Today, MedyMatch announced its third industry engagement to bring MedyMatch’s A.I.-based clinical decision support application to imaging experts working in hospital emergency rooms and other acute care settings.

November 28, 2017

·

2 min read

Business

Base Pair Biotechnologies Completes $3.2M Series A-3 Financing Round and Opens New Facility

Toronto-based Eventi Capital Partners Inc. and Base Pair Canada led the round, with participation from earlier investors Houston-based BioTex, Inc. and Ashok Gowda, BioTex’s President & CEO, one of Base Pair’s founders.

November 28, 2017

·

2 min read